Detailed
Compact
Art
Reverse
September 13, 2019
More from ESC: Antiplatelets and NOACs, blood glucose control, high sensitivity troponin tests, and ICD trials are all covered by John Mandrola, MD, in this week’s podcast.
September 6, 2019
Six major trials from the ESC meeting in Paris are reviewed by John Mandrola, MD, in this week’s podcast.
August 30, 2019
Digital health, a new LDL-c lowering drug, PCSK9i outcomes in higher risk patients, and an ESC preview are discussed by John Mandrola in this week’s podcast.
August 23, 2019
TAVR, baroreflex activation for heart failure, dapagliflozin for HF, and myocardial viability are the topics discussed by John Mandrola in this week’s podcast.
August 16, 2019
AI for AF detection, syncope and PE, thoracentesis, fish oil, and why doctors should organize are the topics covered by John Mandrola in this week’s podcast.
August 2, 2019
Digoxin, acupuncture and angina, heart failure with preserved ejection fraction, bariatric surgery, and cardiac device complications are the topics John Mandrola covers in this week's podcast.
July 26, 2019
CRT in patients with non-LBBB, ezetimibe, lifestyle diseases in the young, end of life care, and diabetes for the cardiologist are the topics John Mandrola, MD discusses in this week's podcast
July 19, 2019
Deprescribing beta bockers, interrupting oral anticoagulants, sudden death, quality measures, and acute stroke care are the topics John Mandrola, MD discusses in this week’s podcast.
July 14, 2019
High-sensitivity troponin assays, nursing education, negative risk markers, valve-in-valve TAVRs, and the use of AI in medical practice are covered in this week’s podcast.
June 28, 2019
Medical reversals, conflict of interest in the cardiac cath lab, cardiologist burnout, and changes in TAVR rules are discussed by John Mandrola, MD, in this week's podcast.
June 21, 2019
FDA hearings on paclitaxel devices in PAD, health news spin, myocarditis, difficult conversations, and TAVR in patients with end stage renal disease (ESRD) are discussed in this week’s podcast.
June 14, 2019
Vitamin D, ICD in patients on dialysis, aspirin, type 2 diabetes, and paclitaxel in PAD are the topics covered by John Mandrola in this week’s podcast.
June 7, 2019
Complications of PCI, health hubs, AV block after TAVR, VTE prevention, and rivaroxaban use in patients with heart failure are the topics discussed by Dr John Mandrola in this week's podcast.
May 31, 2019
Tricuspid valve repair, aortic stenosis, His-bundle pacing, deprescribing loop diuretics, and ‘leakage’ are covered in this week’s podcast.
May 24, 2019
Aspirin and ICH, late tPA for stroke, public reporting of outcomes, Impella, grapefruit juice and QT interval, and ICDs for primary prevention are discussed in this week’s podcast.
May 17, 2019
Renal and AF ablation in combination, infection risk of devices, neuromodulation of AF, pulsed field ablation and stroke of unknown source are covered in a HRS-heavy podcast.
May 10, 2019
Spin in the cardiovascular literature, palliative care for cardiac patients, tPA for acute stroke, and whether institutional volume affects AF ablation complications are the topics discussed this week.
May 3, 2019
Bike commuting and obesity, CMR for NSTEMI, Niacin in secondary prevention, cardiologists’ pay, and end-of-life conversations are in this week’s podcast.
April 19, 2019
Anticoagulation for embolic stroke of unknown origin, added-sugar labels, AF-patient knowledge, LDL-C and hemorrhagic stroke, and genetic signals in cancer-care cardiomyopathy are discussed this week.
April 12, 2019
Super-saturated oxygen in STEMI, Medicaid expansion and CV mortality, pacemakers in patients with HFpEF, HF readmissions, and exercise vs diet for weight loss are discussed in this week’s podcast.
April 5, 2019
ARB recalls, bystander compression-only CPR, renal denervation for hypertension, LDL cholesterol targets, and pre-op frailty are the topics discussed in this week’s podcast.
March 29, 2019
Catheter ablation for atrial fibrillation, eggs, booze, and anti-thrombotic agents for double vs triple therapy in patients with ACS and AF are discussed in this week’s podcast.
March 22, 2019
From ACC.19 and EHRA: The Apple Heart study, TAVR for low-surgical-risk AS, preventing cardiac device infections, COACT, VF arrest, and AF cardioversion are discussed in this week's podcast.
March 15, 2019
Obesity paradox studies and collider bias, the ISCHEMIA trial baseline findings, expanded indications for the MIitraClip, and an ACC preview are covered in this week’s podcast.
March 8, 2019
N of 1 hypertension trials, heart failure readmissions and HRRP, insulin, CTA vs functional stress testing, and the ongoing paclitaxel PAD controversy are discussed in this week’s podcast.
March 1, 2019
Lead extraction, AF triggers, cognitive decline and CV risk factors, low-value care, and secondary prevention in the real world are discussed in this week’s podcast.
February 22, 2019
Factor Xa reversal agent Andexa, PTSD, gender transition hormones and CVD, primary care physician shortage, and a commentary from a young interventional cardiologist are discussed this week.
February 15, 2019
The cost of cardiac care, statin adherence and mortality, syncope, ultra-processed food, and heart failure survival are discussed in this week's podcast.
February 8, 2019
Statins in the elderly, donor hearts and the opioid crisis, Impella, coronary calcium in exercisers, and the plateau in heart disease deaths are discussed in this week’s podcast.
February 1, 2019
New guidelines for atrial fibrillation, PFO closure for stroke prevention, fried chicken, skipping breakfast and e-cigarettes are discussed in this week’s podcast.
January 25, 2019
Aspirin for primary prevention, alcohol and Afib, high-sensitivity troponin, and women in interventional cardiology are discussed in this week’s podcast.
January 18, 2019
Burnout, aspiration thrombectomy, fish intake, insurance coverage, and the gout drug febuxostat are discussed in this week’s podcast.
January 11, 2019
Appropriate use criteria for imaging, HRRP efficacy, medical marijuana, radiation exposure in the cath lab, and hormone therapy are the topics discussed this week’s podcast.
January 4, 2019
The cost of treating high blood pressure, heart-failure readmission policies, abdominal fat, low flow/low gradient aortic stenosis and hypertensive disorders of pregnancy are discussed this week.
December 21, 2018
Dr John Mandrola discusses upcoding for PCI, hypertension, a pacing lead issue, a PAD trial discovery, and an FDA warning on fluoroquinolones in this week’s podcast.
December 14, 2018
Carotid stents, more stem-cell retractions, AHA statement on statin safety, flu vaccine rules, medication errors, veterans care, and wasteful NIH research on golfing are discussed in this week’s podcast.
December 7, 2018
Measures of hospital quality, statin under- or over-use, Botox for AF, smoking cessation and translating trial evidence to clinical practice are discussed in this week’s podcast.
November 30, 2018
TAVR vs surgery for high-risk aortic stenosis, conflicts of interest for physicians and societies, spin in the CV literature, and low-carb diets are discussed in this week’s podcast.
November 16, 2018
The top 5 studies from the recent American Heart Association meeting and the new cholesterol guidelines are discussed in this week’s podcast.
November 9, 2018
ODYSSEY PCSK9 inhibitor trial in print, new bradycardia guidelines, echocardiography, and an AHA preview are the topics discussed in this week’s podcast.
November 2, 2018
CV outcomes in patients with type 2 diabetes, canagliflozin, cardiorespiratory fitness, the value of randomized trials, and the most important paper of 2018 are reviewed in this week’s podcast.
October 26, 2018
Oxygen supplementation, PCSK9 inhibitor pricing, rapid troponin testing, cardio-oncology and joint commission accreditation are discussed in this week’s podcast.
October 19, 2018
Low-dose rivaroxaban for CAD/PAD, hypertension management in the community, research misconduct, cyber-security in cardiac devices, and bariatric surgery are discussed in this week’s podcast.
October 12, 2018
Timing of aortic valve replacement, rivaroxaban failure post TAVR, statins beyond CVD, conflicts of interest, and post-stent antithrombotic management are discussed in this week’s podcast.
September 28, 2018
The COAPT MitraClip trial, high dose omega-3 fatty acids, the VEST trial in print, renal denervation for resistant hypertension, and competing coronary stents are discussed in this TCT-heavy podcast.
September 21, 2018
ASA, polypharmacy, statins and obesity treatments are the topics discussed by Dr John Mandrola in this week’s podcast
September 14, 2018
The Apple Watch EKG, ablate/pace strategies, chronic total occlusion-PCI, assisted reproduction strategies and CV health, and remembering Ron Victor, MD are the topics for this week’s podcast.
September 7, 2018
High sensitivity troponin, radial access (a good news story!), stroke care, rivaroxaban in CAD and PAD, and the components of a healthy diet are discussed in this week’s podcast.
August 24, 2018
The salt wars, drug costs and vaule, Takotsubo syndrome, carb intake, and the upcoming European Society of Cardiology congress are discussed in this week’s podcast
August 17, 2018
Screening athletes, AF ablation complications, physician gender and MI mortality, the rise of chronic kidney disease, and the rosuvastatin lawsuit are discussed in this week's podcast.
August 10, 2018
AF screening, atrial flutter, palliative care in heart failure, and LDL-C lowering are discussed in this week's podcast
August 3, 2018
Aspirin dosing, a potential new drug for SVT, apixaban in patients with ESRD, TAVR, and saunas, are discussed in this week's podcast
July 27, 2018
Leadless pacing, AF detection, coronary calcium, BP control and omega-3 fatty acids are discussed in this week's podcast.
July 13, 2018
Questionable ICD use, ambulatory blood pressure monitoring, multivitamins and cardiovascular health, and end-of-life care are discussed in this week's podcast
June 29, 2018
Dr John Mandrola discusses controversy over the ISCHEMIA trial, AAA screening, PCSK9i in diabetes, cardiac arrest and Twitter in this week’s podcast
June 22, 2018
PREDIMED (again), malpractice concerns in CAD testing, alcohol, stroke care in the elderly, and genetic testing are the topics discussed by Dr John Mandrola in this week’s podcast
June 15, 2018
Nutrition education for docs, PREDIMED retraction, recommendations for ECG screening of healthy adults, and MOC studies are discussed in this week's podcast.
June 8, 2018
Better equations for CV risk prediction, a drug for bradycardia, illicit drugs and MI in the young, EHR woes, and vitamins for CV risk reduction are discussed in this week's podcast.
June 1, 2018
Surgical left atrial appendage occlusion, renal denervation, a substudy of ORBITA, FFR and hypertension guidelines are discussed in this week's podcast.
May 18, 2018
Device-related thrombosis with Watchman left atrial appendage closure, debulking atrial fibrillation after ablation, rivaroxaban for stroke prevention, alteplase, and Lp(a) are discussed this week.
May 11, 2018
The CABANA trial on catheter ablation in patients with atrial fibrillation is discussed in this week’s podcast recorded at the Heart Rhythm Scientific Sessions.
May 4, 2018
AHA rescinds sections of the stroke guidelines, thrombectomy for pulmonary embolism, Mitra-clip, nuts and AF, and blood pressure measurements are discussed in this week's podcast.
April 27, 2018
Lipid-lowering and baseline LDL-C, the CV safety of NSAIDs, 'metabolically healthy' obesity, PCI for chronic total occlusions, and wearable tech are discussed in this week's podcast.
April 20, 2018
Ambulatory BP measurements, advanced practice providers, medical marijuana for sleep apnea, Barbara Bush's comfort care, and apixaban for cardioversion are the topics discussed in this week's podcast.
April 13, 2018
Atrial fibrillation after cardiac surgery, long QT syndrome, exercise for CV prevention, a new risk factor for mothers, and coronary obstruction post TAVR are discussed in this week's podcast.
April 6, 2018
Beta-blockers in diabetes, ACE inhibitors vs ARBs, cardiac implantable electronic device infections, alcohol and AF, and strengthening the p value threshold are discussed in this week's podcast.
March 30, 2018
Dr. John Mandrola discusses heart failure care, methamphetamine, AF ablation, lead extraction, and myocardial injury after noncardiac surgery in this week's podcast.
March 23, 2018
His-bundle pacing, Factor Xa reversal, heart failure quality measures, predicting prognosis after cardiac arrest, and myocarditis after cancer immunotherapy are discussed in this week's podcast.
March 16, 2018
ODYSSEY, VEST, mSTOPS, CANTOS, and the Black barbershop blood pressure study are among the presentations from the 2018 American College of Cardiology meeting reviewed in this week's podcast.
March 9, 2018
Obesity in young people, type-2 diabetes, the risks of varicose veins, on-pump vs off-pump coronary artery bypass surgery and an ACC preview are the topics discussed in this week's podcast.
March 2, 2018
Vegetarian vs Mediterranean diets, a clarithromycin alert, a new stent, best choice of IV fluid, and early work in prevention Type I diabetes are discussed in this week's podcast.
February 23, 2018
Atrial fibrillation after cardiac surgery, radial vs ulnar cath access, aspirin for heart failure, VTE prophylaxis and low-fat vs high-carb diets are discussed in this week's podcast.
February 16, 2018
ICD use in patients with CKD, PFO and peri-operative stroke, LV assist devices, guideline-directed medical therapy after revascularization, and upcoming trials in 2018 are discussed in this week's podcast.
February 9, 2018
Genetic risk scores and early onset CAD, ECGs in athletes, the ripple effect of weight loss, troponin in sepsis, and fish oil for CVD prevention are the topics discussed in this week's podcast.
February 2, 2018
Loperamide abuse, heart failure quality measures, and the CASTLE-AF ablation study are discussed in this week's podcast.
January 26, 2018
Surgical left atrial appendage closure, the effects of smoking and influenza on CV risk, acute stroke care, and why cardiologists are an unhappy bunch are discussed by Dr Mandrola this week.
January 19, 2018
MRI in patients with cardiac devices, bariatric surgery, statins, the LifeVest wearable defibrillator, and spontaneous coronary dissection are the topics discussed in this week's podcast.
January 12, 2018
Exercise effects on left ventricular compliance, CT in stable angina, MRI in patients with cardiac devices, a win for pharma, and ECG screening in adults are discussed in this week's podcast.
December 15, 2017
Noninvasive VT ablation, Riata leads, NOAC/DOAC therapies, HDL-C and infection risk, and fibrosis in triathletes are discussed in this week's podcast.
December 8, 2017
Mobile ECGs, PFO closure for migraine, AF care, lytic and mechanical removal of VTE and the PSCK9 inhibitor evolocumab are discussed in this week's podcast.
December 1, 2017
Sports preparticipation screening, cell therapy in PAD, exercise, supplements, and US healthcare policy are reviewed in this week’s podcast.
November 17, 2017
New hypertension guidelines, BP measurement, DOACs during device surgery, a CANTOS substudy, and conflicting data on the heart-failure readmissions reduction program are discussed this week.
November 10, 2017
Dr John Mandrola discusses PCI in stable CAD, MR, exercise, AHA preview, and celebrities at medical meetings in this week's podcast.
November 3, 2017
The ORBITA sham-control PCI study, Watchman, revascularization in cardiogenic shock, Absorb BVS, quality-of-life outcomes after PCI or bypass, and chronic total occlusion PCI are discussed in this week's podcast.
October 27, 2017
Statins tied to diabetes risk and reduced bacterial infections, a novel use for hs-troponin, mitral-regurgitation management, and His-bundle pacing are reviewed in this week's podcast.
October 20, 2017
Secondary AF, Heart failure statistics, DOAC bleeding rates, uncontrolled hypertension and stroke risk factors are discussed by John Mandrola in this week's podcast.
October 13, 2017
Noninvasive tests for chest pain evaluation, the obesity epidemic, the costs of cardiac device recalls, and DOAC-drug interactions are reviewed in this week's podcast.
October 6, 2017
Stopping aspirin, TAVR durability, meditation, triathlon risk, and BP control in low-income patients are discussed by Dr Mandrola in this week's podcast.
September 29, 2017
Oxygen therapy in stroke, physical activity, hospital rankings, MRI labeling of cardiac devices, and PFO closure are discussed in this week's podcast.
September 22, 2017
PCSK9 drugs and diabetes, allegations against St Jude Medical, trends in carotid interventions, food as medicine, and death with dignity are discussed by Dr John Mandrola in this week's podcast.
September 15, 2017
PFO closure for recurrent stroke prevention, hormone replacement in women, DAPT, obesity, and fentanyl are discussed in this week's podcast.
    15
    15
      0:00:00 / 0:00:00